Inhibition of TDP-43 Aggregation by Nucleic Acid Binding

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Huang, Yi Chen ^a,b   Lin, Ku Feng ^b   He, Ruei Yu ^b   Tu, Pang Hsien ^c   Koubek, Jiri ^b   Hsu, Yin Chih ^b   Huang, Joseph Jen Tse ^a,b  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^b INSTITUTE OF CHEMISTRY   (Taiwan)

^c INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

SINGLE STRANDED DNA; SINGLE STRANDED RNA; TAR DNA BINDING PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CONTROLLED STUDY; ENZYME INHIBITION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN POLYMERIZATION; PROTEIN PURIFICATION; RETICULOCYTE; SOLUBILITY; THERMODYNAMICS; TURBIDITY;

ANIMALS; CELL LINE, TUMOR; CELL-FREE SYSTEM; DNA, SINGLE-STRANDED; DNA-BINDING PROTEINS; ESCHERICHIA COLI; HUMANS; MICE; MUTATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; PROTEIN TRANSPORT; RABBITS; RETICULOCYTES; RNA; SOLUBILITY;

EID: 84878476630     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0064002     Document Type: Article

References (51)

1. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133.
2. Wang IF, Chang HY, Hou SC, Liou GG, Way TD, et al. (2012) The self-interaction of native TDP-43 C terminus inhibits its degradation and contributes to early proteinopathies. Nat Commun 3: 766.
3. Pesiridis GS, Tripathy K, Tanik S, Trojanowski JQ, Lee VM, (2011) A "two-hit" hypothesis for inclusion formation by carboxyl-terminal fragments of TDP-43 protein linked to RNA depletion and impaired microtubule-dependent transport. J Biol Chem 286: 18845-18855.
4. Zhang T, Mullane PC, Periz G, Wang J, (2011) TDP-43 neurotoxicity and protein aggregation modulated by heat shock factor and insulin/IGF-1 signaling. Hum Mol Genet 20: 1952-1965.
5. Dewey CM, Cenik B, Sephton CF, Johnson BA, Herz J, et al. (2012) TDP-43 aggregation in neurodegeneration: Are stress granules the key? Brain Res 1462: 16-25.
6. Amador-Ortiz C, Lin WL, Ahmed Z, Personett D, Davies P, et al. (2007) TDP-43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease. Ann Neurol 61: 435-445.
7. Lin WL, Dickson DW, (2008) Ultrastructural localization of TDP-43 in filamentous neuronal inclusions in various neurodegenerative diseases. Acta Neuropathol 116: 205-213.
8. Schwab C, Arai T, Hasegawa M, Yu S, McGeer PL, (2008) Colocalization of transactivation-responsive DNA-binding protein 43 and huntingtin in inclusions of Huntington disease. J Neuropathol Exp Neurol 67: 1159-1165.
9. Kuo PH, Doudeva LG, Wang YT, Shen CK, Yuan HS, (2009) Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res 37: 1799-1808.
10. Parker SJ, Meyerowitz J, James JL, Liddell JR, Crouch PJ, et al. (2012) Endogenous TDP-43 localized to stress granules can subsequently form protein aggregates. Neurochem Int 60: 415-424.
11. Gendron TF, Josephs KA, Petrucelli L, (2010) Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration. Neuropathol Appl Neurobiol 36: 97-112.
12. Liu-Yesucevitz L, Bilgutay A, Zhang YJ, Vanderweyde T, Citro A, et al. (2010) Tar DNA binding protein-43 (TDP-43) associates with stress granules: analysis of cultured cells and pathological brain tissue. PLoS One 5: e13250.
13. Sendtner M, (2011) TDP-43: multiple targets, multiple disease mechanisms? Nat Neurosci 14: 403-405.
14. Chen-Plotkin AS, Lee VM, Trojanowski JQ, (2010) TAR DNA-binding protein 43 in neurodegenerative disease. Nat Rev Neurol 6: 211-220.
15. Furukawa Y, Kaneko K, Nukina N, (2011) Molecular properties of TAR DNA binding protein-43 fragments are dependent upon its cleavage site. Biochim Biophys Acta 1812: 1577-1583.
16. Gitler AD, Shorter J, (2011) RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion 5: 179-187.
17. Buratti E, Baralle FE, (2001) Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J Biol Chem 276: 36337-36343.
18. Buratti E, Brindisi A, Pagani F, Baralle FE, (2004) Nuclear factor TDP-43 binds to the polymorphic TG repeats in CFTR intron 8 and causes skipping of exon 9: a functional link with disease penetrance. Am J Hum Genet 74: 1322-1325.
19. Voigt A, Herholz D, Fiesel FC, Kaur K, Muller D, et al. (2010) TDP-43-mediated neuron loss in vivo requires RNA-binding activity. PLoS One 5: e12247.
20. Ayala YM, Pantano S, D'Ambrogio A, Buratti E, Brindisi A, et al. (2005) Human, Drosophila, and C.elegans TDP43: nucleic acid binding properties and splicing regulatory function. J Mol Biol 348: 575-588.
21. Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, et al. (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem 280: 37572-37584.
22. Ayala YM, Zago P, D'Ambrogio A, Xu YF, Petrucelli L, et al. (2008) Structural determinants of the cellular localization and shuttling of TDP-43. J Cell Sci 121: 3778-3785.
23. Wang IF, Wu LS, Shen CK, (2008) TDP-43: an emerging new player in neurodegenerative diseases. Trends Mol Med 14: 479-485.
24. Zhang YJ, Gendron TF, Xu YF, Ko LW, Yen SH, et al. (2010) Phosphorylation regulates proteasomal-mediated degradation and solubility of TAR DNA binding protein-43 C-terminal fragments. Mol Neurodegener 5: 33.
25. Furukawa Y, Kaneko K, Watanabe S, Yamanaka K, Nukina N, (2011) A seeding reaction recapitulates intracellular formation of Sarkosyl-insoluble transactivation response element (TAR) DNA-binding protein-43 inclusions. J Biol Chem 286: 18664-18672.
26. Johnson BS, Snead D, Lee JJ, McCaffery JM, Shorter J, et al. (2009) TDP-43 is intrinsically aggregation-prone, and amyotrophic lateral sclerosis-linked mutations accelerate aggregation and increase toxicity. J Biol Chem 284: 20329-20339.
27. Fuentealba RA, Udan M, Bell S, Wegorzewska I, Shao J, et al. (2010) Interaction with polyglutamine aggregates reveals a Q/N-rich domain in TDP-43. J Biol Chem 285: 26304-26314.
28. Zhang YJ, Xu YF, Cook C, Gendron TF, Roettges P, et al. (2009) Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity. Proc Natl Acad Sci U S A 106: 7607-7612.
29. Dewey CM, Cenik B, Sephton CF, Dries DR, Mayer P 3rd, et al (2011) TDP-43 is directed to stress granules by sorbitol, a novel physiological osmotic and oxidative stressor. Mol Cell Biol 31: 1098-1108.
30. Wang IF, Chang H-Y, Hou S-C, Liou G-G, Way T-D, et al. (2012) The self-interaction of native TDP-43 C terminus inhibits its degradation and contributes to early proteinopathies. Nat Commun 3: 766.
31. Polymenidou M, Cleveland DW, (2011) The seeds of neurodegeneration: prion-like spreading in ALS. Cell 147: 498-508.
32. Johnson BS, McCaffery JM, Lindquist S, Gitler AD, (2008) A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity. Proc Natl Acad Sci U S A 105: 6439-6444.
33. Cordeiro Y, Machado F, Juliano L, Juliano MA, Brentani RR, et al. (2001) DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation. J Biol Chem 276: 49400-49409.
34. Gomes MP, Millen TA, Ferreira PS, e Silva NL, Vieira TC, et al. (2008) Prion protein complexed to N2a cellular RNAs through its N-terminal domain forms aggregates and is toxic to murine neuroblastoma cells. J Biol Chem 283: 19616-19625.
35. Diaz-Espinoza R, Soto C, (2012) High-resolution structure of infectious prion protein: the final frontier. Nat Struct Mol Biol 19: 370-377.
36. Silva JL, Lima LM, Foguel D, Cordeiro Y, (2008) Intriguing nucleic-acid-binding features of mammalian prion protein. Trends Biochem Sci 33: 132-140.
37. Hegde ML, Vasudevaraju P, Rao KJ, (2010) DNA induced folding/fibrillation of alpha-synuclein: new insights in Parkinson's disease. Front Biosci 15: 418-436.
38. Giraldo R, Moreno-Diaz de la Espina S, Fernandez-Tresguerres ME, Gasset-Rosa F, (2011) RepA-WH1 prionoid: a synthetic amyloid proteinopathy in a minimalist host. Prion 5: 60-64.
39. Silva JL, Vieira TC, Gomes MP, Bom AP, Lima LM, et al. (2010) Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins. Acc Chem Res 43: 271-279.
40. Ishimaru D, Ano Bom AP, Lima LM, Quesado PA, Oyama MF, et al. (2009) Cognate DNA stabilizes the tumor suppressor p53 and prevents misfolding and aggregation. Biochemistry 48: 6126-6135.
41. Nishimoto Y, Ito D, Yagi T, Nihei Y, Tsunoda Y, et al. (2010) Characterization of alternative isoforms and inclusion body of the TAR DNA-binding protein-43. J Biol Chem 285: 608-619.
42. Winton MJ, Igaz LM, Wong MM, Kwong LK, Trojanowski JQ, et al. (2008) Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J Biol Chem 283: 13302-13309.
43. Lin KF, Sun CS, Huang YC, Chan SI, Koubek J, et al. (2012) Cotranslational protein folding within the ribosome tunnel influences trigger-factor recruitment. Biophys J 102: 2818-2827.
44. Chang CK, Wu TH, Wu CY, Chiang MH, Toh EK, et al. (2012) The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity. Biochem Biophys Res Commun 425: 219-224.
45. Liachko NF, Guthrie CR, Kraemer BC, (2010) Phosphorylation promotes neurotoxicity in a Caenorhabditis elegans model of TDP-43 proteinopathy. J Neurosci 30: 16208-16219.
46. Chen AK, Lin RY, Hsieh EZ, Tu PH, Chen RP, et al. (2010) Induction of amyloid fibrils by the C-terminal fragments of TDP-43 in amyotrophic lateral sclerosis. J Am Chem Soc 132: 1186-1187.
47. Choi SI, Han KS, Kim CW, Ryu KS, Kim BH, et al. (2008) Protein solubility and folding enhancement by interaction with RNA. PLoS One 3: e2677.
48. Rentzeperis D, Jonsson T, Sauer RT, (1999) Acceleration of the refolding of Arc repressor by nucleic acids and other polyanions. Nat Struct Biol 6: 569-573.
49. Cohen TJ, Hwang AW, Unger T, Trojanowski JQ, Lee VM, (2012) Redox signalling directly regulates TDP-43 via cysteine oxidation and disulphide cross-linking. EMBO J 31: 1241-1252.
50. Meyerowitz J, Parker SJ, Vella LJ, Ng D, Price KA, et al. (2011) C-Jun N-terminal kinase controls TDP-43 accumulation in stress granules induced by oxidative stress. Mol Neurodegener 6: 57.
51. Kang D, Yelin D, Bouma BE, Tearney GJ, (2009) Spectrally-encoded color imaging. Opt Express 17: 15239-15247.